Chemed (CHE) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.4B
Gross Profit
854.3M
35.14%
Operating Income
366.9M
15.09%
Net Income
302.0M
12.42%
EPS (Diluted)
$19.89
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
549.6M
Shareholders Equity
1.1B
Debt to Equity
0.49
Cash Flow Metrics
Operating Cash Flow
393.2M
Free Cash Flow
368.0M
Revenue & Profitability Trend
Chemed Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.4B | 2.3B | 2.1B | 2.1B | 2.1B |
| Cost of Goods Sold | 1.6B | 1.5B | 1.4B | 1.4B | 1.4B |
| Gross Profit | 854.3M | 798.8M | 765.1M | 769.8M | 701.4M |
| Operating Expenses | 424.4M | 395.1M | 358.7M | 366.7M | 255.1M |
| Operating Income | 366.9M | 342.8M | 347.2M | 344.0M | 389.7M |
| Pre-tax Income | 399.5M | 350.4M | 329.7M | 350.3M | 396.0M |
| Income Tax | 97.5M | 77.9M | 80.1M | 81.8M | 76.5M |
| Net Income | 302.0M | 272.5M | 249.6M | 268.6M | 319.5M |
| EPS (Diluted) | $19.89 | $17.93 | $16.53 | $16.85 | $19.48 |
Income Statement Trend
Chemed Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 394.7M | 500.8M | 272.6M | 230.3M | 329.4M |
| Non-Current Assets | 1.3B | 1.2B | 1.2B | 1.1B | 1.1B |
| Total Assets | 1.7B | 1.7B | 1.4B | 1.3B | 1.4B |
| Liabilities | |||||
| Current Liabilities | 285.7M | 312.0M | 297.2M | 302.4M | 299.1M |
| Non-Current Liabilities | 263.9M | 248.2M | 346.1M | 417.1M | 234.6M |
| Total Liabilities | 549.6M | 560.2M | 643.3M | 719.4M | 533.7M |
| Equity | |||||
| Total Shareholders Equity | 1.1B | 1.1B | 798.7M | 623.3M | 901.2M |
Balance Sheet Composition
Chemed Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 302.0M | 272.5M | 249.6M | 268.6M | 319.5M |
| Operating Cash Flow | 393.2M | 319.5M | 300.1M | 306.2M | 483.9M |
| Investing Activities | |||||
| Capital Expenditures | 3.3M | 640.0K | 2.3M | 904.0K | 1.7M |
| Investing Cash Flow | -94.4M | -3.8M | -2.1M | 918.0K | -2.7M |
| Financing Activities | |||||
| Dividends Paid | -27.1M | -23.5M | -22.0M | -22.0M | -21.1M |
| Financing Cash Flow | -415.7M | -182.0M | -572.9M | -441.8M | -331.4M |
| Free Cash Flow | 368.0M | 273.4M | 252.6M | 249.9M | 430.5M |
Cash Flow Trend
Chemed Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
22.67
Forward P/E
18.67
Price to Book
5.73
Price to Sales
2.73
PEG Ratio
18.67
Profitability Ratios
Profit Margin
12.40%
Operating Margin
14.65%
Return on Equity
26.11%
Return on Assets
14.09%
Financial Health
Current Ratio
1.73
Debt to Equity
12.28
Beta
0.54
Per Share Data
EPS (TTM)
$20.50
Book Value per Share
$81.09
Revenue per Share
$167.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| che | 6.8B | 22.67 | 5.73 | 26.11% | 12.40% | 12.28 |
| HCA Healthcare | 90.8B | 16.75 | -210.13 | 1,605.77% | 8.07% | -106.02 |
| Tenet Healthcare | 15.7B | 10.85 | 3.76 | 28.82% | 7.09% | 152.20 |
| Ensign Group | 8.5B | 27.83 | 4.37 | 17.64% | 7.00% | 104.09 |
| Option Care Health | 5.3B | 25.82 | 3.91 | 15.38% | 4.12% | 90.53 |
| Amedisys | 3.2B | 35.87 | 2.66 | 7.15% | 3.79% | 36.30 |
Financial data is updated regularly. All figures are in the company's reporting currency.